Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;10(2):73-82.
doi: 10.1007/s11910-010-0086-6.

Management of intraventricular hemorrhage

Affiliations

Management of intraventricular hemorrhage

Holly E Hinson et al. Curr Neurol Neurosci Rep. 2010 Mar.

Abstract

Brain hemorrhage is the most fatal form of stroke and has the highest morbidity of any stroke subtype. Intraventricular extension of hemorrhage (IVH) is a particularly poor prognostic sign, with expected mortality between 50% and 80%. IVH is a significant and independent contributor to morbidity and mortality, yet therapy directed at ameliorating intraventricular clot has been limited. Conventional therapy centers on managing hypertension and intracranial pressure while correcting coagulopathy and avoiding complications such as rebleeding and hydrocephalus. Surgical therapy alone has not changed the natural history of the disease significantly. However, fibrinolysis in combination with extraventricular drainage shows promise as a technique to reduce intraventricular clot volume and to manage the concomitant complications of IVH.

PubMed Disclaimer

Conflict of interest statement

Disclosure No other potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1
Severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage treated with conservative therapy, external ventricular drainage (EVD), and EVD with fibrinolysis, based on a systematic review of the literature. a Mortality. b Percentage of patients experiencing a poor outcome. (Adapted from Nieuwkamp et al. [46])
Fig. 2
Fig. 2
Biochemical reactions within the cerebral ventricle after administration of intraventricular tissue plasminogen activator (t-PA, alteplase) in patients with intraventricular hemorrhage (IVH). Fibrin in the blood clot provides binding sites for alteplase and plasminogen. On the fibrin surface, alteplase and intrinsic t-PA have a high affinity for plasminogen, which is converted to plasmin. Plasmin breaks down the blood clot with release of fibrin degradation products. Urokinase does not have specific affinity for fibrin and activates both freely circulating and fibrin-bound plasminogen. Fibrinolysis is terminated by circulating inhibitors of plasminogen, plasminogen activator inhibitor (PAI) 1 and 2; by inactivation of plasmin by α2-antiplasmin; and by clearance of fibrinolytic factors through the liver. Normally, cerebrospinal fluid concentrations of plasminogen and t-PA are minute because of their high molecular weight. Plasminogen and t-PA incorporated within the clot itself likely are most responsible for clot resolution in IVH. IVC—intraventricular catheter

References

    1. Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986;17 (6):1078–1083. - PubMed
    1. Broderick JP, Brott T, Tomsick T, et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78(2):188–191. - PubMed
    1. Woo D, Haverbusch M, Sekar P, et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke. 2004;35(7):1703–1708. - PubMed
    1. Daverat P, Castel JP, Dartigues JF, Orgogozo JM. Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke. 1991;22(1):1–6. - PubMed
    1. Mohr G, Ferguson G, Khan M, et al. Intraventricular hemorrhage from ruptured aneurysm. Retrospective analysis of 91 cases. J Neurosurg. 1983;58(4):482–487. - PubMed

MeSH terms